Unanswered questions on the use of biologics in pediatric asthma

The emergence of biologic therapies for the management of asthma has been a revolutionary change in our capacity to manage this disease. Since the launch of omalizumab, several other biologics have been marketed or are close to being marketed, suggesting that a plethora of monoclonal antibodies can...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieto, Antonio, El-Sayed, Zeinab A., Gómez, René Maximiliano, Hossny, Elham, Jiu-Yao, Wang, Kalayci, Ömer, Morais-Almeida, Mário, Phipatanakul, Wanda, Pitrez, Paulo Marcio, Pozo Beltrán, César Fireth, Xepapadaki, Paraskevi, Papadopoulos, Nikolaos G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656246/
https://www.ncbi.nlm.nih.gov/pubmed/38020283
http://dx.doi.org/10.1016/j.waojou.2023.100837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656246/
https://www.ncbi.nlm.nih.gov/pubmed/38020283
http://dx.doi.org/10.1016/j.waojou.2023.100837

Ejemplares similares